2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO
生物活性
Description
In Vivo
In Vitro
化合物的使用
Kinase Assay
Cell Assay
Animal Administration
参考文献
BML-210 is the novel HDAC inhibitor, and its mechanism of action has not been characterized.In vitro: Cell cycle analysis indicated that HeLa cell treatment with
20 and 30 μM concentration of BML-210 increased the
proportion of cells in G0/G1 phase, and caused accumulation
in subG1, indicating that the cells are undergoing apoptosis. BML-210 inhibits the growth of NB4 cells in dose- and time-dependent manner.
